Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: OMNISCAN

« Back to Dashboard

Omniscan is a drug marketed by Ge Healthcare and is included in two NDAs. It is available from one supplier. There is one patent protecting this drug.

The generic ingredient in OMNISCAN is gadodiamide. One supplier is listed for this compound. Additional details are available on the gadodiamide profile page.

Summary for Tradename: OMNISCAN

Patents:1
Applicants:1
NDAs:2
Suppliers: see list1

Pharmacology for Tradename: OMNISCAN

Clinical Trials for: OMNISCAN

Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
Status: Completed Condition: Chronic Kidney Disease; Renal Insufficiency

A Study of Gadodiamide Injection in Myocardial Perfusion Magnetic Resonance Imaging
Status: Completed Condition: Coronary Artery Disease

A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide
Status: Completed Condition: Renal Artery Stenosis

A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-Iliac Arteries While Using Gadodiamide
Status: Completed Condition: Aorto-Iliac Stenosis; Arterial Occlusive Diseases

A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain
Status: Completed Condition: Brain Pathology

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
Status: Terminated Condition: Glioblastoma Multiforme

Comparative Study of Non-enhanced Versus Contrast Enhanced MR Angiography in Peripheral Arterial Disease on a 3T MR Scanner.
Status: Completed Condition: Peripheral Arterial Disease

Neurovascular Non Contrast-Enhanced MR Angiography at 3T
Status: Recruiting Condition: Neurovascular Diseases

Efficacy and Safety of Primovist in Chinese Patients
Status: Completed Condition: Known or Suspected Focal Liver Lesions

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION022066Sep 5, 2007DISCNNo5,560,903<disabled>Y<disabled>
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION020123Jan 8, 1993RXYes5,560,903<disabled>Y<disabled>
Ge Healthcare
OMNISCAN
gadodiamide
INJECTABLE;INJECTION022066Sep 5, 2007RXYes5,560,903<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc